IL122816A0 - In vivo diabetes test - Google Patents

In vivo diabetes test

Info

Publication number
IL122816A0
IL122816A0 IL12281696A IL12281696A IL122816A0 IL 122816 A0 IL122816 A0 IL 122816A0 IL 12281696 A IL12281696 A IL 12281696A IL 12281696 A IL12281696 A IL 12281696A IL 122816 A0 IL122816 A0 IL 122816A0
Authority
IL
Israel
Prior art keywords
diabetes test
vivo
vivo diabetes
test
diabetes
Prior art date
Application number
IL12281696A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL122816A0 publication Critical patent/IL122816A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
IL12281696A 1995-07-20 1996-07-19 In vivo diabetes test IL122816A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19526561A DE19526561A1 (de) 1995-07-20 1995-07-20 In-vivo-Diabetes-Test
PCT/EP1996/003192 WO1997003704A2 (de) 1995-07-20 1996-07-19 In-vivo-diabetes-test

Publications (1)

Publication Number Publication Date
IL122816A0 true IL122816A0 (en) 1998-08-16

Family

ID=7767366

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12281696A IL122816A0 (en) 1995-07-20 1996-07-19 In vivo diabetes test

Country Status (10)

Country Link
EP (1) EP0839058A2 (de)
JP (1) JPH11509538A (de)
KR (1) KR19990035757A (de)
CN (1) CN1191493A (de)
AU (1) AU6658296A (de)
CA (1) CA2225145A1 (de)
DE (1) DE19526561A1 (de)
IL (1) IL122816A0 (de)
NO (1) NO980252L (de)
WO (1) WO1997003704A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2044197A (en) * 1996-04-01 1997-10-22 Chugai Seiyaku Kabushiki Kaisha Diagnostic composition for diseases accompanied by autoimmune reactions caused by 65k-glutamic acid decarboxylase
US6750201B1 (en) * 1997-10-17 2004-06-15 The Trustees Of The University Of Pennsylvania Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator
KR100681339B1 (ko) * 2004-12-23 2007-02-15 최성환 연탄보일러

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626054A (en) * 1967-10-25 1971-12-07 Bard Hamilton Co Inc Lupus erythematosus skin test
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
CN1112933A (zh) * 1994-01-20 1995-12-06 伯伦格·曼海姆有限公司 抗原特异性活化t淋巴细胞，其检测和用途
DE19525784A1 (de) * 1995-07-14 1997-01-16 Boehringer Mannheim Gmbh Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD)

Also Published As

Publication number Publication date
AU6658296A (en) 1997-02-18
DE19526561A1 (de) 1997-01-23
WO1997003704A2 (de) 1997-02-06
EP0839058A2 (de) 1998-05-06
CN1191493A (zh) 1998-08-26
NO980252D0 (no) 1998-01-20
KR19990035757A (ko) 1999-05-25
CA2225145A1 (en) 1997-02-06
NO980252L (no) 1998-01-20
JPH11509538A (ja) 1999-08-24
WO1997003704A3 (de) 1997-06-05

Similar Documents

Publication Publication Date Title
AU126813S (en) Blood glucose meter
GB9724457D0 (en) Test apparatus
GB9511651D0 (en) Blood Volume Measurement
AU137086S (en) Glucose testing instrument
EP0721109A3 (de) Elektronischer Testfühler mit Multiplexing
GB9724458D0 (en) Test apparatus
GB2307811B (en) Measurement arrangement
ZA964893B (en) Early diagnostic test
GB2327754B (en) Improvements in catalyst testing
KR0135244B1 (en) Probe card
GB2323930B (en) Testing apparatus
IL117407A0 (en) Testing vessel
IL122816A0 (en) In vivo diabetes test
GB9405150D0 (en) Testing vessel
GB9515160D0 (en) Diagnostic test
EP1030859A4 (de) Ras bindendes protein (pre1)
TW308053U (en) Display for physiological measurement
GB9507102D0 (en) Medical test
CA78051S (en) Blood glucose meter
CA78439S (en) Blood glucose meter
FI103300B1 (fi) Mittauslaite
GB9705304D0 (en) Diagnostic test
GB9607346D0 (en) Medical test
GB9405149D0 (en) Medical test
GB9614439D0 (en) Developments in a diagnostic test